C1 dissociation in serum: estimation of free C1q by electroimmunoassay.

A two-stage electroimmunoassay was developed for measuring macromolecular C1 (C1qrs) and free C1q. The method was based on Ca2+ dependent fixation of C1qrs to agarose, followed by immune precipitation of dissociated C1s in the presence of EDTA. Free C1q was estimated from the increase in C1qrs resulting from saturation of C1q in the samples with purified C1r-C1s. The assay system was studied under various experimental conditions. Combined analysis by electroimmunoassay and crossed immunoelectrophoresis indicated that part of the free C1q in undiluted normal serum could be attributed to physiological C1 activation. Owing to concentration dependent C1qrs dissociation the proportion of free C1q increased with the dilution of serum. Results obtained with serum and with purified C1qrs were consistent with the formation of an equimolar C1q:C1r-C1s complex. However, the capacity for C1r-C1s binding appeared to be higher in the purified system than in serum. Serum concentrations of free C1q were high in some of the patients with disease conditions characterized by increased C1 activation, such as systemic lupus erythematosus or primary biliary cirrhosis.

[1]  A. Sjöholm,et al.  Complement components, complement activation, and acute phase response in systemic lupus erythematosus. , 1984, International archives of allergy and applied immunology.

[2]  R. Ziccardi.  The role of immune complexes in the activation of the first component of human complement. , 1984, Journal of immunology.

[3]  K. Reid,et al.  Location of the binding site in subcomponent C1q for plasma fibronectin. , 1984, Acta pathologica, microbiologica, et immunologica Scandinavica. Supplement.

[4]  S. Lindgren,et al.  Complement Components and Activation in Primary Biliary Cirrhosis , 1984, Hepatology.

[5]  R. Harrison.  Human C1 inhibitor: improved isolation and preliminary structural characterization. , 1983, Biochemistry.

[6]  V. Schumaker,et al.  Measurement of the association constants of the complexes formed between intact C1q or pepsin-treated C1q stalks and the unactivated or activated C1r2C1s2 tetramers. , 1983, Molecular immunology.

[7]  B. Gorick,et al.  The binding and activation of the Clr-Cls subunit of the first component of human complement. , 1982, Molecular immunology.

[8]  I. Gigli,et al.  The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q. , 1982, Journal of immunology.

[9]  M. Daha,et al.  Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates. , 1982, Immunology.

[10]  J. Schifferli,et al.  Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. , 1982, Clinical and experimental immunology.

[11]  E. J. Mckay.  A simple two-step procedure for the purification of plasma C1q from different animal species. , 1981, Immunology letters.

[12]  N. Cooper,et al.  Purification and radiolabeling of human C1q. , 1981, Journal of immunology.

[13]  R. Stroud,et al.  The C1q inhibitor in serum is a chondroitin 4-sulfate proteoglycan. , 1981, The Journal of biological chemistry.

[14]  U. Mårtensson,et al.  Activation of Cl, the first component of complement, the generation of Clr-Cls and Cl- inactivator complexes in normal serum by heparin-affinity chromatography. , 1981, Molecular immunology.

[15]  U. Mårtensson,et al.  Immunochemical and functional analysis of a complete C1q deficiency in man: evidence that C1r and C1s are in the native form, and that they reassociate with purified C1q to form macromolecular C1. , 1980, Journal of immunology.

[16]  N. Cooper,et al.  Active disassembly of the first complement component, C-1, by C-1 inactivator. , 1979, Journal of immunology.

[17]  U. Mårtensson,et al.  FORMATION OF COMPLEXES COMPOSED OF Cr, Cs, AND C INACTIVATOR IN HUMAN SERUM ON ACTIVATION OF C1 , 1978, Acta pathologica et microbiologica Scandinavica. Section C, Immunology.

[18]  N. Cooper,et al.  Direct demonstration and quantitation of the first complement component in human serum. , 1978, Science.

[19]  U. Mårtensson,et al.  Studies of C1 subcomponents in chronic urticaria and angioedema. , 1977, International archives of allergy and applied immunology.

[20]  N. Cooper,et al.  The subunit composition and sedimentation properties of human C1. , 1977, Journal of immunology.

[21]  H. Isliker,et al.  Studies on the precursor form of the first component of complement--I. Isolation of the proenzyme forms of Clr and Cls. , 1977, Immunochemistry.

[22]  C. Kamme,et al.  Cl subcomponents in acute pneumococcal otitis media in children. , 1977 .

[23]  U. Mårtensson,et al.  C1 subcomponent conplexes in normal and pathological sera studied by crossed immunoelectrophoresis. , 2009, Acta pathologica et microbiologica Scandinavica. Section C, Immunology.

[24]  H. Colten,et al.  Ultracentrifugation of the first component of complement: effects of ionic strength. , 1968, Journal of immunology.

[25]  C. Hinz,et al.  CHROMATOGRAPHIC RESOLUTION OF THE FIRST COMPONENT OF HUMAN COMPLEMENT INTO THREE ACTIVITIES , 1963, The Journal of experimental medicine.